학술논문

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
Document Type
Article
Author
Behr, JürgenKreuter, MichaelJohow, JohannesRabe, Klaus FBonella, FrancescoBonnet, ReinerGrohe, ChristianHeld, MatthiasWilkens, HeinrikeHammerl, PeterKoschel, DirkBlaas, StefanWirtz, HubertFicker, Joachim HNeumeister, WolfgangSchönfeld, NicolausClaussen, MartinKneidinger, NikolausFrankenberger, MarionHummler, SimoneKahn, NicolasTello, SilkeFreise, JuliaWelte, TobiasNeuser, PetraGünther, AndreasSchade-Brittinger, CarmenAminossadati, BehnazNasemann, ChristianYahiaoui, SorayaDupuy Backofen, ChristophHahmann, MaikWittenberg, MichaelDrakopanagiotakis, Fotisvon der Beck, DanielGhofrani, StefanieHeinemann, SabineKrauss, EkaterinaRethorn, HellaKoch, AndreaLeuschner, GabrielaMatthes, SandhyaNeurohr, ClausVeit, TobiasMilger-Kneidinger, KatrinHerth, FelixBenstz, JuliaBahmer, ThomasBiller, HeikeWaschki, BenjaminApel, Rosa-MarieCostabel, UlrichBörner, EvaWessendorf, ThomasArnrich, MargretIlie, LacramioaraWald, AlexandraSeyfarth, Hans-JürgenReinhardt, ChristianCinar, AtifVogler, MarkusHuhn, Siegfried MatthiasRichter, JaquelineNeff, UlrichBlum, Torsten GerrietVesenbeckh, SilvanBoch, ChristianSemper, HannesWilke, AndreasPfeifer, MichaelSchweda, AnnetteKrill, AngelikaLensch, ChristianJoa, FranziskaSchröder, BarbaraPlaßmeier, AnnabelBaron, StefanFroehling, Klaus PeterPrasse, AntjeSchönfeld, Nicolas
Source
In The Lancet Respiratory Medicine May 2021 9(5):476-486
Subject
Primary Research
Articles
Language
ISSN
2213-2600